Brightsurf Science News & Current Events

July 23, 2004
URI physical oceanographers receive grant to improve predictions of hurricane intensity
URI Graduate School of Oceanography (GSO) physical oceanographers Drs. Isaac Ginis, Il Ju Moon, and Tetsu Hara have received a three-year $412,000 grant from the National Science Foundation (NSF) to incorporate into current computer models the impact of surface waves on the interaction between the ocean and the atmosphere, and, consequently, how this interaction affects hurricane intensity, track, wind waves, and ocean prediction.

Study suggests stroke-prevention strategy for kids pioneered at MCG is working
The incidence of first stroke in children with sickle cell disease in California has taken a nose-dive since 1998 and the likely reason is a program developed at the Medical College of Georgia to identify and treat kids at risk, a new study says.

K-State professor combines love of teaching, research to examine eye development
In April, a 31-year continuing research project of Gary Conrad's was renewed for another five-year period for $1.825 million.

Scientists pinpoint molecules that generate synapses
Researchers have found a family of molecules that play a key role in the formation of synapses, the junctions that link brain cells, called neurons, to each other.

Cutting-edge cancer researchers sought for international recognition
The American Association for Cancer Research now is accepting nominations for the fourth annual Kirk A. and Dorothy P.

Unlocking the secrets of titanium, a 'key' that assists hydrogen storage
Scientists at Brookhaven National Laboratory and the New Jersey Institute of Technology have taken steps toward understanding how a titanium catalyzes the release and re-absorption of hydrogen.

'Yardangs' on Mars
These images of 'yardangs', features sculpted by wind-blown sand seen here near Olympus Mons on Mars, were obtained by the High Resolution Stereo Camera (HRSC) on board the ESA Mars Express spacecraft.

Optical breast cancer detector
A light-sensitive probe is being developed to help doctors spot breast cancer in some of the 70,000 American women each year whose malignancies fail to show up in needle biopsies.

Men may be best left alone for therapy
New research from the University of Alberta confirms what most women have probably known all along: most men aren't really good at sharing their feelings.

Bone, enamel, dentine, milk & saliva share gene family
Fish and mammal teeth are not created equal. Sometime after the move from spineless to having a backbone, the family of genes that controls tissue mineralization evolved to produce mammalian tooth enamel, bones and dentine, but fish enameloid developed from different genes, according to Penn State researchers.

First International Scientific Conference on Childhood Leukaemia
Children with Leukaemia - Britain's leading charity dedicated exclusively to the conquest of childhood leukaemia - is organising the first international scientific conference ever to be held into the incidence, causes and prevention of childhood leukaemia.

Council voting power affects EU budget shares
This paper examines the determinants of power in the Council of the European Union.

Colleagues to recognize research leadership in cancer detection, prevention and treatment
Continuing a 45-year-old tradition of honoring outstanding achievement in cancer research, the American Association for Cancer Research currently is accepting nominations for its series of annual awards.

Children's Hospital Boston receives more than $10 million to help make smallpox vaccine safer
Children's Hospital Boston (CHB) has secured contracts totaling nearly $10.5 million through the National Institutes of Health to study a potentially life-threatening complication of smallpox immunization known as eczema vaccinatum (EV).

FDA approves new labelling for Seroquel in bioplar mania
AstraZeneca announced today that the U.S. Food and Drug Administration (FDA) has approved additional efficacy labelling information based on 12-week data for SEROQUEL (quetiapine), a psychotropic medication indicated for the treatment of acute manic episodes associated with bipolar I disorder.

Major scientific discovery in cancer research to be honored
Scientists involved in cancer research, cancer medicine or cancer-related biomedical science can nominate a colleague or professional associate whom they believe has advanced significantly the understanding of cancer and whose work holds promise for future contributions for the field for the 8th Pezcoller Foundation-American Association for Cancer Research International Award for Cancer Research.

One taste of growth protein and nerve cells want more
Johns Hopkins researchers report that once a growing nerve

Yale scientists visualize details of how hepatitis C unwinds RNA
Research led by Anna Marie Pyle, professor of molecular biophysics and biochemistry at Yale reveals how a protein from hepatitis C (HCV) unwinds RNA, potentially allowing the virus to be copied.

International Space Station heads of agency meeting
Space agency leaders from the United States, Russia, Japan, Europe and Canada met today at the ESA Technical Centre (ESTEC) in Noordwijk, The Netherlands, to discuss International Space Station (ISS) cooperation activities.

The best view of the Tour is from space
It is now possible to track the position and speed of each rider in the Tour de France in real-time thanks to the EGNOS European satellite positioning system, a preparatory programme for the Galileo system.

Interactive social robots to participate in AAAI's Annual Mobile Robot Challenge
Grace and George, a pair of socially skilled robots developed by a team of researchers from Carnegie Mellon University, the Naval Research Laboratory and Swarthmore College, will participate in the American Association for Artificial Intelligence (AAAI) annual Mobile Robot Competition and Exhibition July 27-29, at the San Jose Convention Center in San Jose, Calif.

FDA approves VYTORIN, first and only to powerfully reduce LDL cholesterol through dual inhibition
Merck/Schering-Plough Pharmaceuticals announces that the FDA has approved Vytorin TM (ezetimibe/simvastatin) for the treatment of high LDL cholesterol in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

Effects of Huntington's disease mutation more complex than supposed
Competing theories about why brain cells die in Huntington's disease may not be competitors after all, according to a report.

CIHR joins in the international registration of randomised controlled trials
Dr. Alan Bernstein, President of the Canadian Institutes of Health Research (CIHR), announced today a new randomized controlled trial policy that will require all CIHR funded clinical trials to register with an International Standard Randomised Controlled Trial Number (ISRCTN).

UCSD launches Industry-University Center for networked systems
UC San Diego and four international technology leaders -- AT&T, Alcatel, HP and QUALCOMM -- have committed approximately $9 million over three years to the Center for Networked Systems (CNS), a new university-industry alliance focused on developing technologies for robust, secure, and open networked systems.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.